Cullinan Therapeutics

CGEMNASDAQ
$16.59
00.00%
Pre-Market: 4:53 PM EDT
15 minutes delayed
Cullinan Therapeutics (CGEM) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$40.00
Lowest Price Target1
$19.00
Consensus Price Target1
$29.14

want to know what
the Bulls & Bears Say?

Cullinan Therapeutics (NASDAQ:CGEM) Stock, Analyst Ratings, Price Targets, Forecasts

Cullinan Therapeutics Inc has a consensus price target of $29.14 based on the ratings of 9 analysts. The high is $40 issued by Stifel on May 1, 2024. The low is $19 issued by Morgan Stanley on February 3, 2023. The 3 most-recent analyst ratings were released by HC Wainwright & Co., HC Wainwright & Co., and Wedbush on June 3, 2024, May 24, 2024, and May 16, 2024, respectively. With an average price target of $30.67 between HC Wainwright & Co., HC Wainwright & Co., and Wedbush, there's an implied 84.85% upside for Cullinan Therapeutics Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Feb
0
0
0
0
Mar
1
Apr
1
May
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Wedbush
Stifel
JonesTrading
BTIG

1calculated from analyst ratings

Analyst Ratings for Cullinan Therapeutics

Buy NowGet Alert
06/03/2024Buy Now68.78%HC Wainwright & Co.
Edward White
$28 → $28ReiteratesBuy → BuyGet Alert
05/24/2024Buy Now68.78%HC Wainwright & Co.
Edward White
 → $28ReiteratesBuy → BuyGet Alert
05/16/2024Buy Now117%Wedbush
Robert Driscoll
 → $36ReiteratesOutperform → OutperformGet Alert
05/16/2024Buy Now68.78%HC Wainwright & Co.
Edward White
$29 → $28MaintainsBuyGet Alert
05/01/2024Buy Now141.11%Stifel
Bradley Canino
 → $40Initiates → BuyGet Alert
04/17/2024Buy Now56.72%JonesTrading
Soumit Roy
$22 → $26MaintainsBuyGet Alert
04/17/2024Buy Now80.83%BTIG
Kaveri Pohlman
$20 → $30MaintainsBuyGet Alert
04/16/2024Buy Now74.8%HC Wainwright & Co.
Edward White
$34 → $29MaintainsBuyGet Alert
04/15/2024Buy Now—William Blair
Matt Phipps
—Initiates → OutperformGet Alert
03/14/2024Buy Now104.94%HC Wainwright & Co.
Edward White
 → $34ReiteratesBuy → BuyGet Alert
02/15/2024Buy Now80.83%Wedbush
Robert Driscoll
 → $30Initiates → OutperformGet Alert
10/06/2023Buy Now32.61%JonesTrading
Soumit Roy
 → $22Initiates → BuyGet Alert
08/11/2023Buy Now104.94%HC Wainwright & Co.
Edward White
$49 → $34ReiteratesBuy → BuyGet Alert
08/09/2023Buy Now195.36%HC Wainwright & Co.
Edward White
 → $49Reiterates → BuyGet Alert
07/07/2023Buy Now195.36%HC Wainwright & Co.
Edward White
 → $49ReiteratesBuy → BuyGet Alert
06/15/2023Buy Now—TD Cowen
Marc Frahm
—Initiates → OutperformGet Alert
06/05/2023Buy Now195.36%HC Wainwright & Co.
Edward White
 → $49ReiteratesBuy → BuyGet Alert
05/26/2023Buy Now195.36%HC Wainwright & Co.
Edward White
 → $49ReiteratesBuy → BuyGet Alert
05/12/2023Buy Now195.36%HC Wainwright & Co.
Edward White
$50 → $49MaintainsBuyGet Alert
03/27/2023Buy Now201.39%HC Wainwright & Co.
Edward White
 → $50Reiterates → BuyGet Alert
03/10/2023Buy Now201.39%HC Wainwright & Co.
Edward White
 → $50Reiterates → BuyGet Alert
02/15/2023Buy Now201.39%HC Wainwright & Co.
Edward White
 → $50Reiterates → BuyGet Alert
02/03/2023Buy Now14.53%Morgan Stanley
Jeffrey Hung
$27 → $19MaintainsOverweightGet Alert
11/21/2022Buy Now20.55%BTIG
Kaveri Pohlman
 → $20Initiates → BuyGet Alert
05/13/2022Buy Now50.69%SVB Leerink
Andrew Berens
$36 → $25MaintainsOutperformGet Alert
03/18/2022Buy Now219.47%HC Wainwright & Co.
Edward White
$55 → $53MaintainsBuyGet Alert

FAQ

Q

What is the target price for Cullinan Therapeutics (CGEM) stock?

A

The latest price target for Cullinan Therapeutics (NASDAQ:CGEM) was reported by HC Wainwright & Co. on June 3, 2024. The analyst firm set a price target for $28.00 expecting CGEM to rise to within 12 months (a possible 68.78% upside). 14 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Cullinan Therapeutics (CGEM)?

A

The latest analyst rating for Cullinan Therapeutics (NASDAQ:CGEM) was provided by HC Wainwright & Co., and Cullinan Therapeutics reiterated their buy rating.

Q

When was the last upgrade for Cullinan Therapeutics (CGEM)?

A

There is no last upgrade for Cullinan Therapeutics

Q

When was the last downgrade for Cullinan Therapeutics (CGEM)?

A

There is no last downgrade for Cullinan Therapeutics.

Q

When is the next analyst rating going to be posted or updated for Cullinan Therapeutics (CGEM)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Cullinan Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Cullinan Therapeutics was filed on June 3, 2024 so you should expect the next rating to be made available sometime around June 3, 2025.

Q

Is the Analyst Rating Cullinan Therapeutics (CGEM) correct?

A

While ratings are subjective and will change, the latest Cullinan Therapeutics (CGEM) rating was a reiterated with a price target of $28.00 to $28.00. The current price Cullinan Therapeutics (CGEM) is trading at is $16.59, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch